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R2 increased to 0.44 (P<0.05). Finally, a model which included WHR, Head fat, and
Upper Body fat yielded a maximal R2 of 0.47 (P<0.05), an improvement over either set of
measurements alone. Conclusion: Simple measures when used alone are as effective as
more sophisticated methods like DEXA for predicting SI in a healthy population. However,
when these measures are combined there is a small increased predictive power. 
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Background: The Wausau SCHOOL Project is a community-based effort to assess the
frequency of cardiovascular risk factors in students in the Wausau School District. Objec-
tive: Define the incidence of elevated BMI and determine its relationship to standard lipid
profiles, homeostatic model assessment of insulin resistance (HOMA-IR), LDL particle
size and number. Methods: Age and sex adjusted BMI (zBMI), fasting plasma insulin,
glucose levels and nuclear magnetic resonance lipid profiles (LipoScience®) was mea-
sured in 225 randomly selected students (110 in 2nd grade and 125 in 11th grade). Over-
weight was defined as zBMI > 85th centile based on 2000 CDC norms. Results: Over
31% of the students were classified as overweight. (30.6% in 2nd grade and 32.5% in
11th grade). HOMA-IR values were significantly higher for 11th graders than for 2nd grad-
ers (2.18±2.65 vs. 1.22± 1.07, p<0.01). HOMA-IR values were also significantly higher
for females than for males (2.04±2.66 vs. 1.33±0.94, p<0.05). Those with zBMI above the
85th centile had significantly higher levels of total cholesterol (182.0±34.0 vs. 170.2±28.5,
p<0.01), LDL (123.4±28.5 vs. 112.7±25.7, p<0.01), triglycerides (118.6±80.7 vs.
86.4±35.6, p<0.001), LDL particle number (1299.8±379.5 vs. 1135±248.0, p<0.001), and
HOMA-IR (2.61±3.47 vs. 1.32±0.09, p< 0.001), while HDL levels were lower (43.7±10.0
vs. 47.5 ±9.7, p<0.01). There were no significant differences in LDL particle size. Con-
clusions: A significant percentage of children and adolescents are overweight. IR
increases significantly with age and zBMI and is associated with an atherogenic lipid pro-
file characterized by an increase in the number of small LDL particles and TG levels and
lower HDL levels, similar to that seen in adults.
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Background: The mechanisms responsible for interindividual variation in response to sta-
tin therapy remain uncertain. Bile acid biosynthesis is one of the determinants of intracel-
lular cholesterol and, in turn, cholesterol synthesis rate in hepatocytes. This raises the
hypothesis that variation in the cholesterol 7α-hydroxylase gene (CYP7A1), a key
enzyme in bile acid biosynthesis, may influence the statin response. Methods and
Results:To test this hypothesis, we examined a promoter polymorphism (A–290C) in
CYP7A1 in 324 hypercholesterolemic patients treated with atorvastatin 10mg. The
CYP7A1 polymorphism was significantly and independently associated with poor LDL
cholesterol response. Mean reductions were -39% in wild type allele homozygotes, -37%
in variant allele heterozygotes, and -34% in variant allele homozygotes, respectively
(p<0.0001 for linear trend). The effects of this polymorphism were more striking in men
than in women and were enhanced by the coexistence of common variants of the apoli-
poprotein E gene (APOE), ε2 or ε4. In subjects having wild type alleles at both loci, the
mean reduction in LDL cholesterol was -40%, while in subjects having two CYP7A1 vari-
ant alleles and at least one variant APOE allele, the mean reduction in LDL cholesterol
was -31% (p<0.0001). In addition, combination analysis of these two polymorphsims
more accurately predicted the achievement of goal LDL cholesterol, than did both single
polymorphism analysis. Conclusions:The CYP7A1 A–290C promoter variant was signifi-
cantly and independently associated with poor response to atorvastatin. The effects of
this polymorphism were additively enhanced, when common variants in another locus,
APOE, coexist.
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Objective
Sphingomyelin (SM) is one of the major phospholipids in the cell membrane and in lipo-
proteins. In human plasma, SM is mainly found in atherogenic lipoproteins, thus, high lev-
els of SM may promote atherogenesis. 
Methods
To further evaluate the role of SM in atherosclerosis, we measured plasma SM levels in
1,102 patients with coronary artery disease (CAD) and 444 healthy controls.
Results
We demonstrated that plasma SM in CAD patients was significantly higher than in con-
trols (51.8 versus 44.9 mg/dl; p < 0.001). Logistic regression analysis showed that
plasma SM was significantly associated with incidence of CAD (OR: 4.9, 95% CI 3.4 –
7.0, for subjects in the fourth quartile in comparison to subjects in the first quartile).
Plasma SM levels showed a strongest and significant correlation with plasma apolipopro-
tein B (apoB)- (r=0.34, p < 0.001) and triglycerides -levels (r=0.31, p < 0.001) in all sub-
jects, respectively. The association between SM and incidence of CAD remained
independently significant after adjustment for most potential confounders including apoB
and triglyceride, such that patients within the fourth quartile of SM revealed a 6.0 fold
(95% CI 3.4 – 7.0) increase of risk.
Conclusion
These results reveal that the proatherogenic potency of human plasma SM levels, as
shown in this study by significantly elevated levels of SM in patients, could be related to
abnormal apoB -containing or triglyceride -rich lipoprotein metabolism.
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841-1 Ceramide Triggers Weibel-Palade Body Exocytosis
Rinky Bhatia, Kenji Matsushita, Munekazu Yamakuchi, Craig Morrell, Charles J. 
Lowenstein, Johns Hopkins University School of Medicine, Baltimore, MD
Background: The sphingolipid ceramide mediates a variety of stress responses, including
vascular inflammation and thrombosis. Activated endothelial cells release Weibel-Palade
bodies, granules containing vWF and P-selectin, which induce leukocyte rolling and
platelet adhesion and aggregation. We hypothesized that ceramide induces vascular
inflammation and thrombosis in part by triggering Weibel-Palade body exocytosis.
Methods: We added ceramide to human aortic endothelial cells (HAEC) and assayed
Weibel-Palade body exocytosis by measuring the concentration of vWF released into the
media.
Results: Exogenous ceramide induces vWF release from endothelial cells in a dose-
dependent manner. As little as 10 nM ceramide induces a 50% maximal release of vWF.
Activators of endogenous ceramide production, neutral sphingomyelinase or tumor
necrosis factor-a (TNF-a), also induce Weibel-Palade body exocytosis. We next studied
the effects of nitric oxide (NO) on ceramide-induced Weibel-Palade body exocytosis,
since NO can inhibit vascular inflammation. The NO donor S-nitroso-penicillamine
(SNAP) decreases ceramide induced vWF release in a dose-dependent manner: the
IC50% for SNAP inhibition of vWF release is < 1 uM. In contrast, the NOS inhibitor L-
nitroarginine methyl ester (L-NAME) increases ceramide induced vWF release.
Conclusions: In summary, our findings show that endogenous ceramide triggers Weibel-
Palade body exocytosis, and that endogenous NO inhibits ceramide induced exocytosis.
These data suggest a novel mechanism by which ceramide induces vascular inflamma-
tion and thrombosis.
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Background. Previous work from our laboratory showed the presence of significant
phagocytic activity in the aortic peri-adventitial fat of animal models of atherosclerosis
(apoE-deficient mice and Watanabe rabbits). The macrophage activity is only mild in the
aortic adventitial fat of wild-type mice and rabbits. In the present study we studied the
adventitial fat of human coronary arteries in patients with plaque ruptures and contrasted
them with those of patients with stable fibrocalcific plaques. We hypothesized that the
macrophagic density would be much greater in the former.
Table. Best ‘Univariate’ Predictors of Insulin Sensitivity
Parameter Estimate t Ratio Pr > t R2
Weight (kg) -0.020 -11.47 <0.0001 0.37
BMI -0.062 -12.77 <0.0001 0.40
Head % Fat -0.040 -12.52 <0.0001 0.41
Upper Body Fat (kg) -0.044 -12.50 <0.0001 0.41
Head Fat (kg) -0.807 -12.78 <0.0001 0.42
Waist (cm) -0.028 -13.38 <0.0001 0.42
* Age and gender were forced into every model.
